These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 20638684)

  • 1. Immuno-expression of human melanoma stem cell markers in tissues at different stages of the disease.
    Sharma BK; Manglik V; Elias EG
    J Surg Res; 2010 Sep; 163(1):e11-5. PubMed ID: 20638684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the stem cell markers nestin and CD133 on circulating melanoma cells.
    Fusi A; Reichelt U; Busse A; Ochsenreither S; Rietz A; Maisel M; Keilholz U
    J Invest Dermatol; 2011 Feb; 131(2):487-94. PubMed ID: 20882037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of CD133 and other putative stem cell markers in uveal melanoma.
    Thill M; Berna MJ; Grierson R; Reinhart I; Voelkel T; Piechaczek C; Galambos P; Jager MJ; Richard G; Lange C; Gehling UM
    Melanoma Res; 2011 Oct; 21(5):405-16. PubMed ID: 21900792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-expression of putative cancer stem cell markers, CD133 and Nestin, in skin tumors.
    Sabet MN; Rakhshan A; Erfani E; Madjd Z
    Asian Pac J Cancer Prev; 2014; 15(19):8161-9. PubMed ID: 25339000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profiling of ABC transporters ABCB5, ABCF2 and nestin-positive stem cells in nevi, in situ and invasive melanoma.
    Setia N; Abbas O; Sousa Y; Garb JL; Mahalingam M
    Mod Pathol; 2012 Aug; 25(8):1169-75. PubMed ID: 22555176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased expression of stem cell markers in malignant melanoma.
    Klein WM; Wu BP; Zhao S; Wu H; Klein-Szanto AJ; Tahan SR
    Mod Pathol; 2007 Jan; 20(1):102-7. PubMed ID: 17143262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The stem cell marker nestin predicts poor prognosis in human melanoma.
    Piras F; Perra MT; Murtas D; Minerba L; Floris C; Maxia C; Demurtas P; Ugalde J; Ribatti D; Sirigu P
    Oncol Rep; 2010 Jan; 23(1):17-24. PubMed ID: 19956860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of putative stem marker nestin and CD133 in advanced serous ovarian cancer.
    Qin Q; Sun Y; Fei M; Zhang J; Jia Y; Gu M; Xia R; Chen S; Deng A
    Neoplasma; 2012; 59(3):310-5. PubMed ID: 22296500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD10 expression by melanoma cells is associated with aggressive behavior in vitro and predicts rapid metastatic progression in humans.
    Thomas-Pfaab M; Annereau JP; Munsch C; Guilbaud N; Garrido I; Paul C; Brousset P; Lamant L; Meyer N
    J Dermatol Sci; 2013 Feb; 69(2):105-13. PubMed ID: 23219141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clonal dominance of CD133+ subset population as risk factor in tumor progression and disease recurrence of human cutaneous melanoma.
    Sharma BK; Manglik V; O'Connell M; Weeraratna A; McCarron EC; Broussard JN; Divito KA; Simbulan-Rosenthal CM; Rosenthal DS; Zapas JL
    Int J Oncol; 2012 Nov; 41(5):1570-6. PubMed ID: 22922842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pathological characteristics of glioma stem cell niches.
    He H; Li MW; Niu CS
    J Clin Neurosci; 2012 Jan; 19(1):121-7. PubMed ID: 22178090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the stem cell markers CD133 and nestin in pancreatic ductal adenocarcinoma and clinical relevance.
    Kim HS; Yoo SY; Kim KT; Park JT; Kim HJ; Kim JC
    Int J Clin Exp Pathol; 2012; 5(8):754-61. PubMed ID: 23071857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Isolation and characterization of brain tumor stem cells in human medulloblastoma].
    Li MC; Deng YW; Wu J; Chen FH; Liu JF; Fang JS
    Ai Zheng; 2006 Feb; 25(2):241-6. PubMed ID: 16480595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell surface Nestin is a biomarker for glioma stem cells.
    Jin X; Jin X; Jung JE; Beck S; Kim H
    Biochem Biophys Res Commun; 2013 Apr; 433(4):496-501. PubMed ID: 23524267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Finding the root of the problem: the quest to identify melanoma stem cells.
    Abel EV; Aplin AE
    Front Biosci (Schol Ed); 2011 Jun; 3(3):937-45. PubMed ID: 21622243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue microarray analysis of ezrin, KBA.62, CD166, nestin, and p-Akt in melanoma versus banal and atypical nevi, and nonmelanocytic lesions.
    Shanesmith RP; Smart C; Cassarino DS
    Am J Dermatopathol; 2011 Oct; 33(7):663-8. PubMed ID: 21915031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD133+ and nestin+ tumor-initiating cells dominate in N29 and N32 experimental gliomas.
    Bexell D; Gunnarsson S; Siesjö P; Bengzon J; Darabi A
    Int J Cancer; 2009 Jul; 125(1):15-22. PubMed ID: 19291792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of multidrug resistance genes in normal and cancer stem cells.
    Shervington A; Lu C
    Cancer Invest; 2008 Jun; 26(5):535-42. PubMed ID: 18568776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD133 and ABCB5 as stem cell markers on sentinel lymph node from melanoma patients.
    Gazzaniga P; Cigna E; Panasiti V; Devirgiliis V; Bottoni U; Vincenzi B; Nicolazzo C; Petracca A; Gradilone A
    Eur J Surg Oncol; 2010 Dec; 36(12):1211-4. PubMed ID: 20573479
    [No Abstract]   [Full Text] [Related]  

  • 20. [Correlative study of distribution of brain tumor stem cell with micro-vascular system].
    Li MW; Niu CS
    Zhonghua Yi Xue Za Zhi; 2010 Feb; 90(5):305-9. PubMed ID: 20368050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.